References
[1] Lamagni T, Guy R, Chand M, Henderson KL, Chalker V, Lewis J, et al. Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. Lancet Infect Dis. 2018;18(2):180-7. doi:10.1016/S1473-3099(17)30693-X.
[2] Shmueli M, Lendner I, Ben-Shimol S. Effect of the COVID-19 pandemic on the pediatric infectious disease landscape. Eur J Pediatr. 2024;183(3):1001-9. doi:10.1007/s00431-023-05210-x.
[3] Balasubramanian S, Amperayani S, Dhanalakshmi K, Senthilnathan S, Chandramohan V. Rapid antigen diagnostic testing for the diagnosis of group A beta-haemolytic streptococci pharyngitis. Natl Med J India. 2018;31(1):8-10. doi:10.4103/0970-258X.243433.
[4] Plainvert C, Duquesne I, Touak G, Dmytruk N, Poyart C. In vitro evaluation and comparison of 5 rapid antigen detection tests for the diagnosis of beta-hemolytic group A streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2015;83(2):105-11. doi:10.1016/j.diagmicrobio.2015.06.012.
[5] Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. Atlanta: CDC; 2019. Available from: www.cdc.gov/DrugResistance/Biggest-Threats.html. doi:10.15620/cdc:82532.
[6] Kurt-Azap Ö. Invasive Group A Beta-Hemolytic Streptococcal (iGAS) Infections: Is There a Public Health Threat? Infect Dis Clin Microbiol. 2023;5(1):63-5. doi:10.36519/idcm.2023.220.
[7] The Lancet Microbe. Strep A treatment, working for now. Lancet Microbe. 2023;4(1):e1. doi:10.1016/S2666-5247(22)00360-3.
[8] Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Executive summary: Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):1279-82. doi:10.1093/cid/cis847.
[9] Cillóniz C, Garcia-Vidal C, Ceccato A, Torres A. Antimicrobial resistance among Streptococcus pneumoniae. In: Fong IW, editor. Anti-microbial Resistance in the 21st Century. Cham: Springer; 2018. p.13-38. doi:10.1007/978-3-319-78538-7_2.
[10] World Health Organization. Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: WHO; 2024.
[11] Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19(11):1209-18. doi:10.1016/S1473-3099(19)30446-3.
[12] Abo YN, Oliver J, McMinn A, Osowicki J, Baker C, Clark JE, et al. Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac. 2023;41:100873. doi:10.1016/j.lanwpc.2023.100873.
[13] Bush LM, Vazquez-Pertejo MT. Streptococcal Infections. In: MSD Manual Professional Version [Internet]. 2023. Available from: https://www.msdmanuals.com/professional/infectious-diseases/gram-positive-cocci/streptococcal-infections
[14] Patterson MJ. Streptococcus. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston: University of Texas Medical Branch; 1996. Chapter 13. Available from: https://www.ncbi.nlm.nih.gov/books/NBK7611/
[15] Koning R, van Roon MA, Brouwer MC, van de Beek D. Adjunctive treatments for pneumococcal meningitis: a systematic review of experimental animal models. Brain Commun. 2024;3:fcae131. doi:10.1093/braincomms/fcae131.
[16] Wang J, Hu L, Zhang Z, Sui C, Zhu X, Wu C, et al. Mice fatal pneumonia model induced by less-virulent Streptococcus pneumoniae via intratracheal aerosolization. Future Microbiol. 2024;19(12):1055-70. doi:10.1080/17460913.2024.2355738.
[17] Ginders M, Leschnik M, Künzel FKD, Mikula C, Steindl G, Eichhorn I, et al. Characterization of Streptococcus pneumoniae isolates from Austrian companion animals and horses. Acta Vet Scand. 2017;59:79. doi:10.1186/s13028-017-0348-2.
[18] Singh BR. Labtop for Microbiology Laboratory. Berlin: Lambert Academic Publishing; 2009.
[19] Brenner DJ, Krieg NR, Staley JT, Garrity GM. Bergey's Manual of Systematic Bacteriology. Vol 2: The Proteobacteria, Part B: The Gammaproteobacteria. 2nd ed. New York: Springer; 2005.
[20] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. Wayne: CLSI; 2020.
[21] Singh BR, Kumar A, Yadav A, Karthikeyan R, Agri H, Jayakumar V. Comparative antimicrobial efficacy of methanolic and diethyl ether extracts of Rose (Rosa Indica) hip seeds against clinically important microbes. J Herb Med Plants. 2022;1(1):1-10. Available from:
http://scientificeminencegroup.com/articles/JHMP/Comparative-Antimicrobial-Efficacy-of-Methanolic.pdf
[22] Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Screening for asymptomatic bacteriuria in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(12):1188-94. doi:10.1001/jama.2019.13069.
[23] Singh BR, Pawde AM, Singh SV, Agri H, Sinha DK, Vinodhkumar OR, et al. Ear infections in animals in Bareilly: Common causes and effective antimicrobials. Austin J Vet Sci Anim Husb. 2019;6(3):1061.
[24] Singh BR, Sinha DK, Singh KP, Pawde AM. Antimicrobial susceptibility of bacterial causes of abortions and metritis in buffaloes (Bubalus bubalis) in Bareilly region, Uttar Pradesh, India. Acta Sci Vet Sci. 2024;6(3):82-92.
[25] Proma P, Goncalvez BP, Le Doare K, Lawn E. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention. Curr Opin Pediatr. 2023;35(2):223-30. doi:10.1097/MOP.0000000000001223.
[26] Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65(Suppl 2):S200-19. doi:10.1093/cid/cix664.
[27] Waller AS, Paillot R, Timoney JF. Streptococcus equi: a pathogen restricted to one host. J Med Microbiol. 2011;60(Pt 9):1231-40. doi:10.1099/jmm.0.028233-0.
[28] Timoney JF. The pathogenic equine streptococci. Vet Res. 2004;35(4):397-409. doi:10.1051/vetres:2004025.
[29] Kaplan EL, Gerber MA. Group A, group C, and group G beta-hemolytic streptococcal infections. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia: Saunders; 2009. p.1225-39.
[30] Baracco GJ. Infections caused by Group C and G Streptococcus (Streptococcus dysgalactiae subsp. equisimilis and others): Epidemiological and clinical aspects. Microbiol Spectr. 2019;7(2). doi:10.1128/microbiolspec.GPP3-0016-2018.
[31] Dekker JP, Lau AF. An Update on the Streptococcus bovis Group: Classification, identification, and disease associations. J Clin Micro-biol. 2016;54(7):1694-9. doi:10.1128/JCM.02977-15.
[32] Hughes JM, Wilson ME, Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis. 2009;49(5):766-72. doi:10.1086/605085.
[33] Tabata A, Nakano K, Ohkura K, Tomoyasu T, Kikuchi K, Whiley RA, et al. Novel twin streptolysin S-like peptides encoded in the sag operon homologue of beta-hemolytic Streptococcus anginosus. J Bacteriol. 2013;195(5):1090-9.
[34] Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. Gram-positive cocci. In: Koneman's Color At-las and Textbook of Diagnostic Microbiology. 7th ed. Philadelphia: Wolters Kluwer; 2017. p.1009-18.
[35] Giuliano S, Rubini G, Conte A, Goldoni P, Falcone M, Vena A, et al. Streptococcus anginosus group disseminated infection: case report and review of literature. Infez Med. 2012;20(3):145-54.
[36] Keighley MRB, Williams NS, Church JM, Pahlman L, Scholefield JH, Scott NA. Surgery of the Anus, Rectum & Colon. 3rd ed. London: Saunders; 2008. p.2169-214.
[37] Shinzato T, Saito A. The Streptococcus milleri group as a cause of pulmonary infections. Clin Infect Dis. 1995;21(Suppl 3):S238-43. doi:10.1093/clind/21.supplement_3.s238.
[38] Pagnossin D, Smith A, Oravcová K, Weir W. Streptococcus canis, the underdog of the genus. Vet Microbiol. 2022;273:109524. doi:10.1016/j.vetmic.2022.109524.
[39] Taniyama D, Abe Y, Sakai T, Kikuchi T, Takahashi T. Human case of bacteremia caused by Streptococcus canis sequence type 9 harboring the scm gene. IDCases. 2017;7:48-52. doi:10.1016/j.idcr.2017.01.002.
[40] Timoney J, Velineni S, Ulrich B, Blanchard P. Biotypes and scm types of isolates of Streptococcus canis from diseased and healthy cats. Vet Rec. 2017;180(14):358.
[41] Wente N, Krömker V. Streptococcus dysgalactiae-contagious or environmental? Animals (Basel). 2020;10(11):2185. doi:10.3390/ani10112185.
[42] Wente N, Grieger AS, Klocke D, Paduch JH, Zhang Y, Leimbach S, et al. Recurrent mastitis–persistent or new infections? Vet Microbiol. 2020;244:108682.
doi:10.1016/j.vetmic.2020.108682.
[43] Alves-Barroco C, Caço J, Roma-Rodrigues C, Fernandes AR, Bexiga R, Oliveira M, et al. New insights on Streptococcus dysgalactiae subsp. dysgalactiae isolates. Front Microbiol. 2021;12:686413. doi:10.3389/fmicb.2021.686413.
[44] Nathan B, Pillai V, Ayyan SM, Ss A, Prakash Raju KNJ. Streptococcus dysgalactiae subspecies dysgalactiae infection presenting with septic shock. Cureus. 2021;13(1):e12465. doi:10.7759/cureus.12465.
[45] Martini AM, Moricz BS, Ripperger AK, Tran PM, Sharp ME, Forsythe AN, et al. Association of novel Streptococcus sanguinis virulence factors with pathogenesis in a native valve infective endocarditis model. Front Microbiol. 2020;11:10. doi:10.3389/fmicb.2020.00010.
[46] Paik S, Senty L, Das S, Noe JC, Munro CL, Kitten T. Identification of virulence determinants for endocarditis in streptococcus sanguinis by signature-tagged mutagenesis. Infect Immun. 2005;73(9):6064-74. doi:10.1128/IAI.73.9.6064-6074.2005.
[47] Zhu B, Macleod LC, Kitten T, Xu P. Streptococcus sanguinis biofilm formation & interaction with oral pathogens. Future Microbiol. 2018;13(8):915-32. doi:10.2217/fmb-2018-0043.
[48] Duarte RS, Barros RR, Facklam RR, Teixeira LM. Phenotypic and genotypic characteristics of Streptococcus porcinus isolated from human sources. J Clin Microbiol. 2005;43(9):4592-601. doi:10.1128/JCM.43.9.4592-4601.2005.
[49] Agnew W, Barnes AC. Streptococcus iniae: An aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol. 2007;122(1-2):1-15. doi:10.1016/j.vetmic.2007.03.002.
[50] Nho SW, Shin GW, Park SB, Jang HB, Cha IS, Ha MA, et al. Phenotypic characteristics of Streptococcus iniae and Streptococcus parauberis isolated from olive flounder (Paralichthys olivaceus). FEMS Microbiol Lett. 2009;293(1):20-7. doi:10.1111/j.1574-6968.2009.01491.x.
[51] Cetera V, Cantinotti M, Barberi E, Pak V. Huge, invasive, and destructive Abiotrophia defectiva endocarditis of the aortic valve and the aortic wall: a case report of an emergency but successful Ross-Konno operation in a child. Eur Heart J Case Rep. 2024;8(8):ytae356. doi:10.1093/ehjcr/ytae356.
[52] Pagotto A, Campanile F, Conti P, Prataviera F, Della SP, Flammini S, et al. An aminoglycoside-sparing regimen with double Beta-lactam to successfully treat Granulicatella adiacens prosthetic aortic valve endocarditis-time to change paradigm? Infect Dis Rep. 2024;16(2):249-59. doi:10.3390/idr16020020.
[53] Gupta S, Garg M, Misra S, Singhal S. Granulicatella adiacens abscess: Two rare cases and review. J Lab Physicians. 2018;10(1):121-3. doi:10.4103/JLP.JLP_58_17.
[54] Saad E, Tummala A, Agab M, Rodriguez-Nava G. Gemella morbillorum as the culprit organism of post-colonoscopy necrotizing perineal soft tissue infection in a diabetic patient with Crohn's disease. J Med Cases. 2022;13(3):99-103. doi:10.14740/jmc3896.
[55] Numberger D, Siebert U, Valentin Weigand P. Survival and adaptation of Streptococcus phocae in host environments. PLoS One. 2024;19(1):e0296368.
doi:10.1371/journal.pone.0296368.
[56] Nikolaisen NK, Lindegaard M, Lyhs U, Strube ML, Hansen MS, Struve T, et al. First finding of Streptococcus phocae infections in mink (Neovison vison). Res Vet Sci. 2021;139:145-51. doi:10.1016/j.rvsc.2021.07.015.
[57] Hyink O, Balakrishnan M, Tagg JR. Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol Lett. 2005;252(2):235-41. doi:10.1016/j.femsle.2005.09.003.
[58] Kaci G, Goudercourt D, Dennin V, Pot B, Doré J, Ehrlich SD, et al. Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Appl Environ Microbiol. 2014;80(3):928-34. doi:10.1128/AEM.03133-13.
[59] Vinciguerra M, Santamaria V, Romiti S, D'Abramo M, Toto G, De Bellis A, et al. Case report: Streptococcus alactolyticus as a rare pathogen of mitral endocarditis. Front Cardiovasc Med. 2021;8:648213. doi:10.3389/fcvm.2021.648213.
[60] Beighton D, Hayday H, Russell RRB, Whiley RA. Streptococcus macacae sp. nov. from dental plaque of monkeys (Macaca fascicularis). Int J Syst Evol Microbiol. 1984;34(3):332-5. doi:10.1099/00207713-34-3-332.
[61] Singh BR, Chandra M, Agri H, Karthikeyan R, Yadav A, Jayakumar V. Mammaliicoccus sciuri and M. lentus emerging as cause of lethal infections in animals and birds. Acta Botanica Plantae. 2024:12-8. doi:10.51470/ABP.2024.03.03.12.
[62] Singh BR, Agri H, Yadav A, Jayakumar V, Pawde AM. Comparative herbal and conventional antimicrobial susceptibility patterns of methicillin-resistant (MR) and methicillin-susceptible (MS) staphylococci of clinical and environmental origin. Acta Botanica Plantae. 2024:1-11. doi:10.51470/ABP.2024.03.03.01.
[63] Costinar L, Badea C, Marcu A, Pascu C, Herman V. Multiple drug resistant Streptococcus strains-an actual problem in pig farms in Western Romania. Antibiotics (Basel). 2024;13(3):277. doi:10.3390/antibiotics13030277.
[64] Pompilio A, Di Bonaventura G, Gherardi G. An Overview on Streptococcus bovis/Streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance. Int J Mol Sci. 2019;20(3):480. doi:10.3390/ijms20030480.
[65] Bhardwaj M, Singh BR, Sinha DK, Vadhana P, Vinodhkumar OR, Singh SV, et al. Potential of herbal drug and antibiotic combination therapy: A new approach to treat multidrug-resistant bacteria. Pharm Anal Acta. 2016;7(11):1-4. doi:10.4172/2153-2435.1000523.
[66] Prasanna V, Singh BR, Bhardwaj M, Singh SV. Emergence of herbal antimicrobial drug resistance in clinical bacterial isolates. Pharm Anal Acta. 2015;6:434.
doi:10.4172/21532435.1000434.
[67] Kumar A, Singh BR, Prakash SNJ, Kumar S, Bhagirathi, Ahuja D, et al. Study of antimicrobial efficacy of Garlic oil loaded ethosome against clinical microbial isolates of diverse origin. J Herb Med. 2024;43:100884. doi:10.1016/j.hermed.20s23.100824.